Population structure in a critically endangered arctic fox population: does genetics matter?

The arctic fox (Alopex lagopus) in Scandinavia is classified as critically endangered after having gone through a severe decline in population size in the beginning of the 20th century, from which it has failed to recover despite more than 65 years of protection. Arctic foxes have a high dispersal rate and often disperse over long distances, suggesting that there was probably little population differentiation within Scandinavia prior to the bottleneck. It is, however, possible that the recent decline in population size has led to a decrease in dispersal and an increase in population fragmentation. To examine this, we used 10 microsatellite loci to analyse genetic variation in 150 arctic foxes from Scandinavia and Russia. The results showed that the arctic fox in Scandinavia presently is subdivided into four populations, and that the Kola Peninsula and northwest Russia together form a large fifth population. Current dispersal between the populations seemed to be very low, but genetic variation within them was relatively high. This and the relative F(ST) values among the populations are consistent with a model of recent fragmentation within Scandinavia. Since the amount of genetic variation is high within the populations, but the populations are small and isolated, demographic stochasticity seems to pose a higher threat to the populations' persistence than inbreeding depression and low genetic variation.

Field anesthesia of wild arctic fox (Alopex lagopus) cubs in the Swedish lapland using medetomidine-ketamine-atipamezole.

A safe and effective anesthetic regime for use in arctic fox (Alopex lagopus) cubs was developed. During July 1996, six free-ranging 6-8-wk-old cubs were captured near their den in Vindelfjallen Nature Reserve, Sweden. Medetomidine and ketamine HCI, followed by atipamezole, were selected for the anesthetic trial because of the well-documented safety and efficacy of this drug combination in a broad range of species. The dosage regimen used was 50 microg/kg medetomidine combined with 2.5 mg/kg ketamine followed by reversal with 250 microg/kg atipamezole. Induction was rapid, with a mean induction time of 1 min and 32 sec (range: 58-150 sec). The cubs were anesthetized for a mean time of 18 +/- 5 min (range: 13-25 min). Serially recorded heart rate, respiratory rate, temperature, and pulse oximetry were stable throughout the anesthetic period for all cubs. Anesthetic depth was suitable for safe handling and minor clinical procedures, including venipuncture. Following atipamezole, all cubs were standing within 12 +/- 7 min (range: 5-24 min) and fully recovered at 27 +/- 5 min (range: 19-36 min). This information will be useful for future captive breeding and management programs involving the endangered arctic fox.

Health evaluation of arctic fox (Alopex lagopus) cubs in Sweden.

Hematologic, serum biochemistry, and serum cortisol reference ranges were established and tonsil/rectal bacterial and fecal parasite examinations were performed on 21 wild arctic fox (Alopex lagopus) cubs during July 1996. Several of the hematologic and serum biochemistry values fell within normal ranges for other wild canids or domestic dogs of the same age class. Serum alanine transaminase and creatine phosphokinase values were significantly higher in the youngest cubs. Proteus vulgaris and Escherichia coli were isolated from both tonsilar and rectal swabs of several cubs in all dens. The most common gastrointestinal parasite ova were Toxascaris leonina (59%), Isospora spp. (52%), Uncinaria stenocephala (33%), and Capillaria spp. (26%). Prevalence of T. leonina differed significantly between dens and between age groups. Hematologic and serum biochemistry values and degree of parasitism may be indicators of health, stress, and nutritional status of arctic foxes.